Destiny Pharma Limited

#03167025 Active

Destiny Pharma is a clinical phase biotechnology company focused on developing novel anti-infectives aimed at infection prevention, particularly in hospital settings. Their innovative products target various bacterial infections, enhancing patient safety and outcomes.

Founded: 4 Mar 1996
Industries:
72190 - Other research and experimental development on natural sciences and engineering
Location: London

Products & Services

• anti infectives
• biotechnology
• biotechnology
• clinical phase
• development of novel anti-infectives
• health care
• hospital market
• infection prevention
• ntcd-m3
• pharmaceutical
• xf-73 dermal
• xf-73 nasal

Financial Snapshot

Last accounts made up to 31 Dec 2023
Next accounts due 30 Sept 2025
Cash in Bank
£0.34m
↓ 23%
Turnover
£2.1m
↑ 15%
EBITDA
£0.45m
↑ 8%
Gross Profit
£0.89m
↑ 12%
Total Liabilities
£0.72m
↓ 17%
Employees
14
↑ 0%
Unlock financial data with Pro Start Free Trial →

People

Officers
7
Shareholders
132
Controllers (PSC)
0
Debra Stephanie Barker
Director • Swiss • Lives in Switzerland • Born in Dec 1962
Aled Paton Williams
Director • British • Lives in Switzerland • Born in Feb 1970
James Patrick Stearns
Director • British • Lives in United Kingdom • Born in May 1979
Nigel Stanley Brooksby
Director • British • Lives in United Kingdom • Born in Aug 1950
Nigel Russell Rudd
Director • British • Lives in Portugal • Born in Dec 1946

Registered Office Address

C/O Cork Gully Llp, 40

Villiers Street

London

WC2N 6NJ

Basic Information

LTD
4 Mar 1996
ENGLAND WALES
Yes

Industry Classification

72190

Company Attributes

N/A
N/A
Yes
N/A

Summary

26
Officers
0
PSCs
0
Filings